Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

Item
http://www.wikidata.org/entity/Q24200697
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipientsDelayed-onset cytomegalovirus disease coded during hospital readmission after kidney transplantation.Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.Detection of cytomegalovirus drug resistance mutations by next-generation sequencing.The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States.Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir.Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.Antiviral therapy in cytomegalovirus-positive ulcerative colitis: a systematic review and meta-analysis.KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.Cytomegalovirus-related childhood mortality in Australia 1999-2011.Pharmacokinetics and exposure-response analysis of RG7667, a combination of two anti-cytomegalovirus monoclonal antibodies, in a Phase 2a randomized trial to prevent cytomegalovirus infection in high-risk kidney transplant recipients.Secular Trends in Infection-Related Mortality after Kidney Transplantation.Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?
P2860

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

Item
http://www.wikidata.org/entity/Q24200697
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antiviral medications for prev ...... id organ transplant recipients
@ast
Antiviral medications for prev ...... id organ transplant recipients
@en
Antiviral medications for prev ...... id organ transplant recipients
@en-gb
Antiviral medications for prev ...... id organ transplant recipients
@nl
type
label
Antiviral medications for prev ...... id organ transplant recipients
@ast
Antiviral medications for prev ...... id organ transplant recipients
@en
Antiviral medications for prev ...... id organ transplant recipients
@en-gb
Antiviral medications for prev ...... id organ transplant recipients
@nl
prefLabel
Antiviral medications for prev ...... id organ transplant recipients
@ast
Antiviral medications for prev ...... id organ transplant recipients
@en
Antiviral medications for prev ...... id organ transplant recipients
@en-gb
Antiviral medications for prev ...... id organ transplant recipients
@nl
P1433
P1476
P2093
P2860
P31
P356
P50
P577
P698
P921
P356
P1433
P1476
Antiviral medications for prev ...... id organ transplant recipients
@en
P2093
P2860
P31
P356
10.1002/14651858.CD003774.PUB4
P50
P577
P698
P921